Thomas G. Wiggans - Nov 16, 2023 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role: Director
Signature: By: /s/ Herb Cross, as Attorney-in-Fact
Stock symbol: JSPR
Transactions as of: Nov 16, 2023
Transactions value $: $18,240
Form type: 4
Date filed: 11/20/2023, 08:14 PM
Previous filing: Nov 2, 2023
Next filing: Nov 22, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JSPR	Voting Common Stock	Purchase	$5.97K	+10K		$0.60	10K	Nov 16, 2023	Direct
transaction	JSPR	Voting Common Stock	Purchase	$5.97K	+10K	+100%	$0.60	20K	Nov 17, 2023	Direct	F1
transaction	JSPR	Voting Common Stock	Purchase	$6.31K	+10K	+50%	$0.63	30K	Nov 20, 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5889 to $0.60, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
F2	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.616 to $0.64, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5889 to $0.60, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.616 to $0.64, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.